Análisis: Pembrolizumab Followed by AVD in Untreated Early Unfavorable and Advanced Stage Classical Hodgkin Lymphoma (Blood. DOI:10.1182/blood.2020007400)
Otro
Pembrolizumab Followed by AVD in Untreated Early Unfavorable and Advanced Stage Classical Hodgkin Lymphoma.pdf (2.058Mb)Publication date
2020-10-22Metadata
Show full item record
Cómo citar
Cómo citar
Análisis: Pembrolizumab Followed by AVD in Untreated Early Unfavorable and Advanced Stage Classical Hodgkin Lymphoma (Blood. DOI:10.1182/blood.2020007400)
Abstract
Reunión de análisis de artículo sobre la monoterapia breve con pembrolizumab seguida de AVD y como demostró ser muy eficaz y segura en pacientes con linfoma de Hodgkin clásico
Identifier
URI: https://repositorio.uchile.cl/handle/2250/177884
Collections
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile